Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
To access this article, please choose from the options below
PII: S1368-8375(03)00234-3
doi:10.1016/j.oraloncology.2003.10.010
© 2004 Elsevier Ltd. All rights reserved.
